INVO Bioscience (INVO) Competitors $0.88 +0.03 (+3.66%) As of 07/2/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock INVO vs. BTCY, NURO, TTOO, NAYA, DYNT, IONM, AFIB, GMVDF, NMRD, and MOTSShould you be buying INVO Bioscience stock or one of its competitors? The main competitors of INVO Bioscience include Biotricity (BTCY), NeuroMetrix (NURO), T2 Biosystems (TTOO), NAYA Biosciences (NAYA), Dynatronics (DYNT), Assure (IONM), Acutus Medical (AFIB), G Medical Innovations (GMVDF), Nemaura Medical (NMRD), and Motus GI (MOTS). These companies are all part of the "surgical & medical instruments" industry. INVO Bioscience vs. Its Competitors Biotricity NeuroMetrix T2 Biosystems NAYA Biosciences Dynatronics Assure Acutus Medical G Medical Innovations Nemaura Medical Motus GI INVO Bioscience (NASDAQ:INVO) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and risk. Which has more volatility and risk, INVO or BTCY? INVO Bioscience has a beta of 1.43, suggesting that its stock price is 43% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500. Which has higher valuation and earnings, INVO or BTCY? INVO Bioscience has higher earnings, but lower revenue than Biotricity. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioINVO Bioscience$5.77M0.58-$8.03MN/AN/ABiotricity$12.06M0.87-$14.09M-$1.08-0.39 Is INVO or BTCY more profitable? Biotricity has a net margin of -80.42% compared to INVO Bioscience's net margin of -122.79%. Company Net Margins Return on Equity Return on Assets INVO Bioscience-122.79% N/A -36.94% Biotricity -80.42%N/A -188.47% Do insiders and institutionals hold more shares of INVO or BTCY? 12.0% of INVO Bioscience shares are owned by institutional investors. Comparatively, 3.9% of Biotricity shares are owned by institutional investors. 3.5% of INVO Bioscience shares are owned by company insiders. Comparatively, 10.1% of Biotricity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Do analysts prefer INVO or BTCY? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score INVO Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media favor INVO or BTCY? In the previous week, Biotricity had 2 more articles in the media than INVO Bioscience. MarketBeat recorded 2 mentions for Biotricity and 0 mentions for INVO Bioscience. INVO Bioscience's average media sentiment score of 0.00 equaled Biotricity'saverage media sentiment score. Company Overall Sentiment INVO Bioscience Neutral Biotricity Neutral SummaryBiotricity beats INVO Bioscience on 6 of the 10 factors compared between the two stocks. Get INVO Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for INVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INVO vs. The Competition Export to ExcelMetricINVO BioscienceSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.34M$256.81M$5.49B$9.02BDividend YieldN/AN/A5.38%4.10%P/E RatioN/A5.9227.4720.28Price / Sales0.5873.83408.86121.46Price / CashN/A196.1236.6357.47Price / Book-0.436.128.095.68Net Income-$8.03M-$27.18M$3.17B$248.96M7 Day Performance-15.82%-1.14%2.81%3.30%1 Month Performance-44.59%-7.16%3.67%5.20%1 Year Performance15.18%25.77%35.41%21.37% INVO Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INVOINVO BioscienceN/A$0.88+3.7%N/A+15.2%$3.34M$5.77M0.0025Gap DownBTCYBiotricityN/A$0.39-7.5%N/A-46.5%$9.72M$12.06M-0.3640News CoverageGap DownNURONeuroMetrixN/A$4.55+4.4%N/A+22.0%$9.37M$3.03M-0.9920High Trading VolumeTTOOT2 Biosystems2.4659 of 5 stars$0.15+18.1%$5.00+3,127.9%-97.2%$3.26M$7.68M0.00180Gap UpNAYANAYA BiosciencesN/A$1.22-3.2%$24.00+1,867.2%N/A$813K$6.23M0.0010DYNTDynatronics0.3194 of 5 stars$0.07-8.3%N/A-67.6%$743K$33.60M-0.09200News CoverageGap DownIONMAssureN/A$0.05flatN/A-99.5%$150K$149K0.00130Upcoming EarningsGap DownAFIBAcutus MedicalN/A$0.00+13.8%N/AN/A$98K$7.16M0.00340Gap DownGMVDFG Medical InnovationsN/A$0.00flatN/AN/A$26K$4.42M0.0072NMRDNemaura Medical1.0513 of 5 starsN/AN/A-99.8%$4K$3.02K0.0040MOTSMotus GI0.0825 of 5 stars$0.00flatN/AN/A$2K$319K0.0030 Related Companies and Tools Related Companies Biotricity Competitors NeuroMetrix Competitors T2 Biosystems Competitors NAYA Biosciences Competitors Dynatronics Competitors Assure Competitors Acutus Medical Competitors G Medical Innovations Competitors Nemaura Medical Competitors Motus GI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INVO) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
